Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against ADMA Biologics, Inc.
Prnewswire·2026-03-25 20:01Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against ADMA Biologics, Inc. Accessibility StatementSkip NavigationMILWAUKEE, March 25, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against ADMA (NASDAQ: ADMA). The investigation results from inaccurate statements ADMA may have made regarding its financial statements, business operations and prospects.Click hereto join our investigation or to obtain additional information, or contact us at [email protec ...